x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Medical Device Global Market Access

Navigate every market. Accelerate every launch. Medical Device Global Market Access by Pure Global is the audio briefing that turns the world’s most confusing regulatory pathways into clear, actionable roadmaps. If you’re a MedTech founder, RA/QA leader, product manager, or investor who needs to get devices cleared anywhere from Austin to Abu Dhabi, this show is your shortcut. Why listen? • Step-by-step playbooks – We decode EU MDR, U.S. 510(k), Brazil’s ANVISA, China’s NMPA, and 25 + other

technology

All Episodes

03:20

Home-Use Device Recalls & Firmware Updates:...

Medical Device Global Market Access ·

2026/03/15

This episode delves into the top health technology hazard: the logistical challenges of communicating recalls and firmware updates for home-use medical devices. We explore the fragmented communication chain from manufacturer to patient, the difficulties in executing physical returns and software corrections for non-clinical users, and the regulatory definition of a firmware update as a recall.- Why are home-use device recalls considered the #1 medical tech hazard? - What makes communicating with

en

03:26

Securing the MedTech Supply Chain: Blockchain vs....

Medical Device Global Market Access ·

2026/03/14

The rise of sophisticated 3D-printed counterfeit medical devices presents a grave threat to patient safety and brand integrity. This episode delves into the escalating battle between counterfeiters and MedTech manufacturers, exploring the cutting-edge technologies being deployed to secure the global supply chain. We examine how solutions like blockchain and invisible marking technologies are becoming essential for verifying product authenticity, ensuring traceability, and complying with increasingly

en

03:06

Self-Healing Logistics: Automating Medical Device...

Medical Device Global Market Access ·

2026/03/13

This episode explores the rise of "self-healing" supply chains, an AI-driven solution designed to combat the logistical nightmares caused by modern geopolitical tensions. We examine how these automated networks use predictive analytics to anticipate disruptions, autonomously reroute critical medical device shipments, and maintain regulatory compliance in a volatile world. This shift from reactive to proactive logistics is becoming a necessity for ensuring patient safety and building resilient

en

03:45

AI Diagnostic Bias: Navigating FDA and Global...

Medical Device Global Market Access ·

2026/03/12

This episode explores the growing regulatory pressure on medical device manufacturers to mitigate algorithmic bias in AI-powered diagnostics. We discuss why "black box" algorithms are facing scrutiny, what bodies like the FDA are now requiring as evidence of equitable performance, and the significant risks of failing to address bias, including market withdrawal.- What is "algorithmic bias" in the context of AI medical devices? - Why are regulators demanding transparency in AI models? - What

en

03:07

ASC Sales Strategy: Adapting MedTech for the 2026...

Medical Device Global Market Access ·

2026/03/11

This episode explores the strategic pivot required for MedTech companies as over 500 surgical procedures shift to Ambulatory Surgery Centers (ASCs) by 2026. We break down why traditional hospital-focused sales models are failing in the high-efficiency ASC environment and outline the new logistics, pricing, and value propositions needed to succeed in this rapidly growing market.- Why is the 2026 procedural shift to ASCs a critical challenge for MedTech sales teams? - How do purchasing decisions in

en

02:52

MedTech's Subscription Shift: Surviving the Death of...

Medical Device Global Market Access ·

2026/03/10

This episode explores the pivotal shift in hospital procurement from traditional capital expenditures (CapEx) to subscription-based Device-as-a-Service (DaaS) models. We analyze why this change is occurring and detail its disruptive impact on medical device manufacturers, covering critical adjustments required in revenue recognition, sales compensation, customer relationships, and even product design to thrive in this new service-oriented landscape. Key Questions - Why are hospitals moving away

en

03:02

USA's Breakthrough Device Dilemma: Closing the...

Medical Device Global Market Access ·

2026/03/09

This episode delves into the critical reimbursement gap facing innovative medical devices in the United States. We explore why FDA Breakthrough Device designation doesn't guarantee Medicare payment, the financial "valley of death" this creates for MedTech startups, and how the proposed "Ensuring Patient Access to Critical Breakthrough Products Act" aims to provide a vital four-year bridge of temporary coverage. - What is the FDA's Breakthrough Devices Program? - Why does FDA approval not

en

03:31

Beyond the AI Hype: The Human Validation Bottleneck...

Medical Device Global Market Access ·

2026/03/08

This episode delves into the growing use of agentic AI for drafting complex regulatory dossiers like FDA 510(k)s and EU Technical Files. We explore the paradox where AI's speed in drafting is offset by a massive bottleneck: the intensive, time-consuming process of human-in-the-loop validation. Discover why this crucial verification step is non-negotiable and how it's reshaping the role of regulatory professionals, preventing the promised acceleration to market. Key Questions: - What is "agentic AI"

en

03:31

Cybersecurity in MedTech: Surviving Digital Darkness...

Medical Device Global Market Access ·

2026/03/07

This episode explores the growing threat of 'digital darkness'—total network outages caused by cyberattacks—and its impact on the medical device industry. We delve into the heightened scrutiny from regulatory bodies like the FDA and under the EU MDR, focusing on new requirements for manufacturers to prove their devices can function safely and effectively offline. We discuss key strategies for building cybersecurity resilience, from design and risk assessment to post-market surveillance. Key

en

03:12

Beyond the Clinical Trial: Unlocking MedTech Market...

Medical Device Global Market Access ·

2026/03/06

This episode explores the pivotal shift from traditional clinical trial data to the increasing demand for continuous Real-World Evidence (RWE) for medical devices. We delve into why global regulators and payers now require robust post-market data to prove a device's long-term safety, effectiveness, and value. We also unpack the significant infrastructure and analytical challenges that MedTech companies face in building a compliant and effective RWE program.Key Questions: - What is the difference

en

03:16

EU AI Act: Navigating High-Risk Classification & Dual...

Medical Device Global Market Access ·

2026/03/05

This episode delves into the EU's new Artificial Intelligence Act and its significant impact on medical device manufacturers. We explore the "high-risk" classification for most AI-driven medical devices, the new compliance obligations that run parallel to existing MDR/IVDR requirements, and the critical timelines manufacturers must meet. We break down the challenges and strategies for navigating this dual regulatory framework, from data governance to human oversight.- What is the EU AI Act and why

en

03:21

FDA's QMSR Shift: Harmonizing US Quality Systems with...

Medical Device Global Market Access ·

2026/03/04

This episode breaks down the FDA's final rule transitioning the Quality System Regulation (21 CFR Part 820) to the ISO 13485-aligned Quality Management System Regulation (QMSR). We cover the February 2, 2026, compliance deadline, the key differences and retained FDA requirements, and the strategic steps medical device manufacturers must take to harmonize their global quality documentation and ensure a seamless transition.- What is the FDA's new Quality Management System Regulation (QMSR)? - When

en

03:24

EU MDR Compliance: Surviving the Notified Body...

Medical Device Global Market Access ·

2026/03/03

This episode delves into the critical capacity crisis among Notified Bodies under the EU's Medical Device Regulation (MDR). We explore how the stringent requirements of the MDR, combined with a reduction in the number of designated Notified Bodies, have created a massive bottleneck for certifying new and legacy medical devices. We discuss the significant risk this poses to manufacturers, who face the possibility of their products being forced off the market as old certificates expire, and examine

en

03:12

Countdown to EUDAMED: Mastering the EU's May 2026...

Medical Device Global Market Access ·

2026/03/02

This episode dives into one of the most significant challenges facing medical device manufacturers in 2026—the mandatory EUDAMED registration deadline. We break down what the May 2026 milestone means, the complexities of uploading technical and Unique Device Identification (UDI) data, and the critical steps companies must take now to avoid being locked out of the European Union market. Key Questions: - What is the EUDAMED and why is it critical for EU market access? - When is the final deadline for

en

03:20

Singapore HSA Fees: A Cost Breakdown for Class B, C,...

Medical Device Global Market Access ·

2026/03/01

This episode provides a detailed breakdown of the medical device registration fees charged by Singapore's Health Sciences Authority (HSA). We cover the standard application fee and the specific evaluation costs for Class B, Class C, and Class D devices. The host explains how different evaluation routes—such as Full, Abridged, Expedited, and Immediate—impact the final cost and how leveraging prior approvals from reference agencies can lead to significant savings. - What are the latest HSA

en

02:51

Singapore MedTech Compliance: Mastering the SS 620...

Medical Device Global Market Access ·

2026/02/28

This episode provides a detailed overview of Singapore's mandatory Good Distribution Practice for Medical Devices (GDPMDS) certification. We explore the governing standard, SS 620:2016, and explain why it is an essential requirement enforced by the Health Sciences Authority (HSA) for any company seeking to import or wholesale medical devices in this key Asian market. Learn about the core components of the standard, from quality management systems to traceability and storage, to ensure your supply

en

03:07

Singapore MedTech Market: A Guide to HSA's Importer,...

Medical Device Global Market Access ·

2026/02/27

This episode provides a detailed guide to the three types of medical device dealer licenses required by Singapore's Health Sciences Authority (HSA): manufacturer, importer, and wholesaler. We clarify the specific activities each license permits and highlight the critical, non-negotiable requirement for a compliant Quality Management System (QMS), referencing key standards like GDPMDS and ISO 13485.- What are the three types of dealer licenses for medical devices in Singapore? - If I import a

en

03:04

Navigating Singapore's HSA: The Class A Medical...

Medical Device Global Market Access ·

2026/02/26

This episode delves into a key regulatory pathway in Singapore for low-risk medical devices. We explore the Health Sciences Authority's (HSA) exemption from product registration for Class A non-sterile devices, a crucial topic clarified by guidance from June 1, 2022. We detail the specific requirements that are waived, as well as the crucial obligations that remain, such as dealer licensing and post-market surveillance. This is essential listening for any MedTech company looking to enter the

en

02:52

Unlocking Singapore: Mastering the ASEAN CSDT for...

Medical Device Global Market Access ·

2026/02/25

This episode provides a detailed guide on using the ASEAN Common Submission Dossier Template (CSDT) for medical device registration in Singapore. We cover the structure of the CSDT, specific documentation required by Singapore's Health Sciences Authority (HSA), and how requirements vary based on device risk classification, ensuring you have the information to prepare a successful submission.- What is the ASEAN Common Submission Dossier Template (CSDT)? - How does the CSDT streamline medical device

en

02:45

Singapore HSA Fast-Track: Leveraging FDA, CE Mark &...

Medical Device Global Market Access ·

2026/02/24

This episode explores Singapore's Health Sciences Authority (HSA) abridged evaluation route, a streamlined pathway for medical device registration. We detail how manufacturers can leverage prior approvals from five major reference agencies—including the US FDA and EU Notified Bodies—to accelerate market access for Class B, C, and D devices in this key ASEAN hub. - What are Singapore's five reference regulatory agencies for medical devices? - How can a US FDA approval or EU CE Mark speed up your

en

311 results

Similar Podcasts

Lead With AI

Tamara Nall

Linux in the Ham Shack

Black Sparrow Media

Data Engineering Podcast

Tobias Macey

Eye On A.I.

Craig S. Smith

Reflections

Livewire Labs